Soligenix, Inc.
SNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000812796
No open-market purchases or sales by Soligenix, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $369.6K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Soligenix, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +3 vs. Q1 2026
- Shares held
- 933.5K
- +673.0K (+258.3%) vs. Q1 2026
- Total value
- $369.6K
- +$62.1K (+20.2%) vs. Q1 2026
- New holders
- 6
- 3 more added
- Sold out
- 3
- 3 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $369.6K |
| Q1 2026 | 15 | $307.4K |
| Q4 2025 | 19 | $600.0K |
| Q3 2025 | 23 | $1.61M |
| Q2 2025 | 15 | $248.2K |
| Q1 2025 | 11 | $313.1K |
| Q4 2024 | 10 | $82.8K |
| Q3 2024 | 7 | $262.4K |
| Q2 2024 | 11 | $259.1K |
| Q1 2024 | 18 | $147.3K |
| Q4 2023 | 20 | $289.2K |
| Q3 2023 | 19 | $500.2K |
| Q2 2023 | 20 | $1.02M |
| Q1 2023 | 16 | $195.2K |
| Q4 2022 | 36 | $1.84M |
| Q3 2022 | 30 | $1.35M |
| Q2 2022 | 28 | $1.91M |
| Q1 2022 | 33 | $2.38M |
| Q4 2021 | 28 | $2.25M |
| Q3 2021 | 34 | $4.35M |
| Q2 2021 | 34 | $4.59M |
| Q1 2021 | 35 | $5.22M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Soligenix, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 209,507 | $83.0K | 0.00% | +209,507 | New |
| Jane Street Group, LLC | 207,492 | $82.2K | 0.00% | +207,492 | New |
| XTX Topco Ltd | 157,119 | $62.2K | 0.00% | +136,320+655.4% | Added |
| Geode Capital Management, LLC | 120,267 | $47.6K | 0.00% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 81,005 | $32.1K | 0.00% | +22,605+38.7% | Added |
| Virtu Financial LLC | 60,903 | $24.0K | 0.00% | +60,903 | New |
| Vanguard Fiduciary Trust Co | 53,914 | $21.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 38,046 | $15.1K | 0.00% | +38,046 | New |
| Morgan Stanley | 3,592 | $1.42K | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 1,236 | $507 | 0.00% | +1,136+1,136.0% | Added |
| JPMorgan Chase & Co | 245 | $98 | 0.00% | −60−19.7% | Reduced |
| Plante Moran Financial Advisors, LLC | 209 | $83 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 2 | $1 | 0.00% | −400−99.5% | Reduced |
| Albion Financial Group | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1 | $0 | 0.00% | −1−50.0% | Reduced |
| Royal Bank of Canada | 5 | $0 | 0.00% | +5 | New |
| Caitong International Asset Management Co., Ltd | 1 | $0 | 0.00% | +1 | New |
| UBS Group AG | 0 | $0 | 0.00% | −2,346−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −209−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |